Kaipu Biotech: Announcement on the change of medical device production license for its wholly-owned subsidiary

Securities code: 300639 Stock abbreviation: Kaipu Biotechnology Announcement number: 2026-051

Guangdong Kaipu Biotechnology Co., Ltd.

Announcement on changing the medical device production license of a wholly-owned subsidiary

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.

Recently, Guangzhou Kaipu Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Guangdong Kaipu Biotechnology Co., Ltd., received the "Medical Device Production License" issued by the Guangdong Provincial Food and Drug Administration. This change involves a change in the production scope. The specific contents of the production license are as follows:

License number: Guangdong Food and Drug Administration Equipment Production License No. 20173077

Company name: Guangzhou Kaipu Pharmaceutical Technology Co., Ltd.

Residence: 4th Floor, No. 2 Reagent Workshop, No. 71, Fenghuang Sanheng Road, Zhongxin Knowledge City, Jiulong Town, Huangpu District, Guangzhou Unified social credit code: 91440101MA59AAN02L

Legal representative: Xie Longxu

Person in charge of the company: Guan Zhisheng

Production address: Area A, 601, and 602 on the 6th floor of the production laboratory building, No. 71, Fenghuang Sanheng Road, Zhongxin Knowledge City, Jiulong Town, Huangpu District, Guangzhou City, Guangdong Province; 1st to 4th floors of the No. 2 reagent workshop; Area C, 2nd floor, and 3rd floor B of the warehouse; 2nd floor A, 4th floor A, 5th floor A, and 6th floor A, 601, 602, and 603 of the No. 2 standard workshop

Production scope: Class III 6840 in vitro diagnostic reagents

Valid until: November 16, 2027

Announcement hereby!

Board of Directors of Guangdong Kaipu Biotechnology Co., Ltd.

July 22, 2026